Expo Theater Presentations

​Expo Theater Presentations

We are pleased to announce the following companies will present in the Expo Theater this year. Presentation titles and speaker details to come later this summer.



Thursday, November 5 
  
10:25 AM – 11:25 AM

Veracyte, Inc.​

The Afirma® GRID™ Research Tool Can Help Drive Discovery for Future Patients
Speakers:  Adeeb Ansari, MD, MPH (Veracyte, South San Francisco, CA), Gustavo Romero-Velez, MD (Cleveland Clinic, OH) and Arti Bhan, MD (Henry Ford Health, Detroit, MI)


12:40 PM – 1:40 PM

Acella Pharmaceuticals​​​​​

Desiccated Thyroid Extract for Hypothyroidism: An Evolution of Understanding

Speakers:  David Robertson, MD (Atlanta Diabetes Associates, GA), Timothy Petersen, MD, FACP, FACE, ECNU (TPMG, Virginia Beach, VA) and Thanh D. Hoang DO, MACP, FACE (Uniformed Services University, Bethesda, MD) 

Sponsored by: Acella Pharmaceuticals, LLC

 

2:45 PM – 3:45 PM Immunovant, Inc.​Graves' Disease: Integrating TSHR Autoantibodies into Clinical Decision-Making

​Speakers: Terry F. Davies MB.BS, MD, FRCP, FACE (Icahn School of Medicine at Mount Sinai, New York, NY) and Mark A. Lupo, MD (Florida State University College of Medicine and Thyroid & Endocrine Center of Florida, Tallahassee) 

​Sponsored by: Immunovant, Inc.

 

4:45 PM – 5:45 PM

 SONIC HEALTHCARE USA ThyroSeq Laboratory

New Advances in ThyroSeq® Testing: Refining Risk of RAS Mutations and Predicting Radioiodine Avidity
​​Moderator:  Bryan Haugen, MD (Sonic Healthcare USA)
​Speakers: Yuri Nikiforov, MD, PhD (UPMC, Pittsburgh, PA), Stephanie Fish, MD (Memorial Sloan Kettering Cancer Center, New York, NY) and Gregory W. Randolph, MD (Harvard Medical School, Mass Eye and Ear, Boston, MA) 
​Sponsored by: Sonic Healthcare USA

 

Friday, November 6
  
10:15 AM – 11:15 AM   

 Interpace Diagnostics

From Indeterminate to Informed: Going Beyond Mutations with microRNA Signatures to Improve the Risk Stratification of Thyroid Nodules

​Speakers: Mark Lupo, MD, FACE, ECNU (Thyroid & Endocrine Center of Florida, Sarasota) and Todd Frieze, MD, FACP, FACE, ECNU, CCD (Duke Health, Durham, NC) 

Sponsored by: Interpace Diagnostics®, LLC 

 

12:45 PM – 1:45 PMacendis pharma​​​​

Patient and HCP Perspectives: A Treatment for Hypoparathyroidism

Speakers: Todd Frieze, MD, FACP, FACE, ECNU, CCD (Duke University Medical Center, NC) and Denise (Patient Ambassador)

Sponsored by: Ascendis Pharma

​

2:15 PM – 3:15 PM

 Pulse Biosciences

nPulse™ Vybrance™ Technology with nsPFA™ Energy – A Billionth of a Second Changes Everything

​Moderator:  Ralph Tufano, MD, MBA, FACS (Sarasota Memorial Hospital, FL)

Speakers: Stefano Spiezia, MD (Napoli Ospedale del Mare, Italy), David Goldenberg, MD (Penn State Health, Hershey, PA) and Nate Walsh, MD (Clayman Thyroid Center, Tampa, FL)

​Sponsored by: Pulse Biosciences

 

  
Saturday, November 7
  
8:45 AM – 9:45 AM

 argenx ​​Graves’ Disease Through the Patient Lens: Exploring the Evolving Investigational Landscape

​Moderator/Speaker: Christopher Tubbs, PhD (argenx, Boston, MA)

Speakers:  Anupam Kotwal, MD (University of Nebraska Medical Center, Omaha) and Omar El Kawkgi, MD (University of Kentucky, Lexington)
​Sponsored by: argenx
11:00 AM – 12:00 PM

 argenx ​The Role of the Endocrinologist in Early Recognition of Thyroid Eye Disease
Speaker: Sonalika Khachikian, MD (Monument Health, Rapid City, SD)









8:45 AM – 9:45 AM














Interpace Diagnostics®, LLC





Patient and HCP Perspectives: A Treatment for Hypoparathyroidism





Title: The Role of the Endocrinologist in Early Recognition of Thyroid Eye Disease


Speaker: Sonalika Khachikian, MD (Monument Health, Rapid City, SD)





Gustavo Romero-Velez

New Advances in ThyroSeq® Testing: Refining Risk of RAS Mutations and Predicting Radioiodine Avidity

Speakers: Stefano Spiezia, MD (recorded presentation) (Napoli Ospedale del Mare, Italy), David Goldenberg, MD (Penn State Health, Hershey, PA) and Nate Walsh, MD (Clayman Thyroid Center, Tampa, FL)

Adeeb Ansari, MD, MPH (Veracyte, South San Francisco, CA)

Graves’ Disease Through the Patient Lens: Exploring the Evolving Investigational Landscape

The Afirma® GRID™ Research Tool Helps Drive Discovery for Future Patients

The Afirma® GRID™ Research Tool Can Help Drive Discovery for Future Patients